Retron Gene Editing Patent for Human Cell Genome
Summary
USPTO published patent application US20260091137A1 for Retron directed gene editing technology applicable to human cell genome editing. The application, filed September 15, 2023, by inventors Brian Busser and colleagues, covers compounds, polypeptides, compositions, and nucleic acid molecules for genome editing. Key CPC classifications include gene editing enzymes and genetic constructs.
What changed
USPTO published patent application US20260091137A1 for a Retron directed gene editing system applicable to human cells. The application claims compounds, polypeptides, compositions, and nucleic acid molecules useful for genome editing. Inventors include Brian Busser, Johann Neil Reshan Cooke, Robin L. Armstrong, Gregory Mazo, Glenn Christopher Tan, and Madyson Scherr. Filing date was September 15, 2023, with application number 19111662.
This is a patent application publication providing intellectual property notice rather than imposing compliance obligations. Companies developing gene editing technologies, particularly retron-based systems, should review the claims to assess potential licensing needs or freedom-to-operate implications. Researchers and biotech firms in genetic medicine, therapeutic development, and synthetic biology should monitor this application through the prosecution period.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
RETRON DIRECTED GENE EDITING
Application US20260091137A1 Kind: A1 Apr 02, 2026
Inventors
Brian Busser, Johann Neil Reshan Cooke, Robin L. Armstrong, Gregory Mazo, Glenn Christopher Tan, Madyson Scherr
Abstract
Compounds, polypeptides, compositions, and nucleic acid molecules are provided herein that can be used, for example, to edit the genome of a cell, such as a human cell.
CPC Classifications
A61K 48/0058 C12N 9/1276 C12N 9/226 C12N 15/11 C12N 15/85 C12N 2310/20 C12N 2800/107 C12N 2800/22
Filing Date
2023-09-15
Application No.
19111662
Related changes
Get daily alerts for USPTO Patent Applications - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.